HSBC Holdings
ANAB icon

HSBC Holdings’s AnaptysBio ANAB Stock Holding History

HSBC Holdings’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
216,949
+91,232
+73% +$5.53M 0.01% 850
2026
Q1 		$7.14M Buy
+125,717
New +$6.76M ﹤0.01% 1029
2018
Q1 		– Sell
-9,400
Closed -$947K – 2536
2017
Q4 		$947K Buy
+9,400
New +$692K ﹤0.01% 1303

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

HSBC Holdings's ANAB Position: Q2 2026 in Review

HSBC Holdings increased its AnaptysBio (ANAB) stake by 73% in Q2 2026, buying an estimated $5.53M and bringing the position to 216,949 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #850.

HSBC Holdings first reported a position in ANAB in Q4 2017 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • HSBC Holdings held 216,949 shares of AnaptysBio worth $14.9M as of Q2 2026.
  • HSBC Holdings bought 91,232 AnaptysBio shares in Q2 2026, an estimated $5.53M.
  • AnaptysBio made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #850 holding.
  • HSBC Holdings first reported a position in AnaptysBio in Q4 2017 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.